Skip to main content

Precision science

inspired by human biology.

Vividion Therapeutics is removing the boundaries of druggability to develop therapies for patients with critical unmet needs across multiple therapeutic areas.
A unified team with a singular mission. We are committed to delivering solutions for patients who may have once thought there was no treatment option for their disease.
We are reimagining the “impossible” to deliver possibility for all by combining decades of research with unprecedented know-how. We envision a future where there are treatments for all patients, no matter how difficult their disease is to target. 
Vividion Therapeutics and Roche Jointly Publish Landmark Nature Paper on Clinical-Stage Covalent Allosteric Inhibitor of Werner Helicase (WRN)  
Read more
Vividion Therapeutics starts Phase I clinical trial in advanced solid and hematologic tumors with oral STAT3 inhibitor
Read more
We’re hiring! Come work with a passionate team, pushing the boundaries of what small molecules are capable of.